Lawrence A. Kenyon joined Outlook Therapeutics as CFO and Secretary in September 2015. In August 2018, Mr. Kenyon became the Company’s President and CEO while still serving as CFO and as a member of the board of directors. He has more than 20 years of experience serving in executive and senior management roles at private and public biotechnology, biopharmaceutical, specialty pharma, and financial services companies. He holds a BA in Accounting from the University of Wisconsin-Whitewater.
.svg)
